Zheng Mei, Choi Nahyun, Balboni Gianfranco, Xia Ying, Sung Jong-Hyuk
STEMORE Co. Ltd., Incheon 21983, Republic of Korea.
Department of Life and Environment Sciences, University of Cagliari, Cagliari 09124, Italy.
Biomol Ther (Seoul). 2021 Nov 1;29(6):643-649. doi: 10.4062/biomolther.2021.064.
Literature has revealed that the delta opioid receptor (DOR) exhibited diverse pharmacological effects on neuron and skin. In the present study, we have investigated whether the activation of DOR has hair-growth promotion effects. Compared with other opioid receptor, DOR was highly expressed in epidermal component of hair follicle in human and rodents. The expression of DOR was high in the anagen phase, but it was low in the catagen and telogen phases during mouse hair cycle. Topical application of UFP-512, a specific DOR agonist, significantly accelerated the induction of the anagen in CH mice. Topical application of UFP-512 also increased the hair length in hair organ cultures and promoted the proliferation and the migration of outer root sheath (ORS) cells. Similarly, pharmacological inhibition of DOR by naltrindole significantly inhibited the anagen transition process and decreased hair length in hair organ cultures. Thus, we further examined whether Wnt/β-catenin pathway was related to the effects of DOR on hair growth. We found that Wnt/β-catenin pathway was activated by UFP-512 and siRNA for β-catenin attenuated the UFP-512 induced proliferation and migration of ORS cells. Collectively, result established that DOR was involved in hair cycle regulation, and that DOR agonists such as UFP-512 should be developed for novel hair-loss treatment.
文献显示,δ阿片受体(DOR)对神经元和皮肤表现出多种药理作用。在本研究中,我们调查了DOR的激活是否具有促进头发生长的作用。与其他阿片受体相比,DOR在人和啮齿动物毛囊的表皮成分中高表达。在小鼠毛发周期中,DOR的表达在生长期高,但在退行期和休止期低。局部应用特异性DOR激动剂UFP-512可显著加速CH小鼠生长期的诱导。局部应用UFP-512还可增加毛囊器官培养物中的毛发长度,并促进外根鞘(ORS)细胞的增殖和迁移。同样,纳曲吲哚对DOR的药理抑制作用显著抑制了生长期转变过程,并缩短了毛囊器官培养物中的毛发长度。因此,我们进一步研究了Wnt/β-连环蛋白信号通路是否与DOR对头发生长的影响有关。我们发现,UFP-512激活了Wnt/β-连环蛋白信号通路,而β-连环蛋白的小干扰RNA(siRNA)减弱了UFP-512诱导的ORS细胞增殖和迁移。总体而言,结果表明DOR参与毛发周期调节,应开发UFP-512等DOR激动剂用于新型脱发治疗。